Raymond James Financial
LH icon

Raymond James Financial’s Labcorp LH Stock Holding History

Raymond James Financial’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.6M Sell
103,341
-13,754
-12% -$3.72M 0.01% 1249
2025
Q4 		$29.4M Sell
117,095
-15,569
-12% -$4.13M 0.01% 1181
2025
Q3 		$38.1M Sell
132,664
-26,572
-17% -$7.12M 0.01% 978
2025
Q2 		$41.8M Buy
159,236
+7,982
+5% +$1.94M 0.01% 866
2025
Q1 		$35.2M Buy
151,254
+3,952
+3% +$959K 0.01% 922
2024
Q4 		$33.8M Buy
+147,302
New +$33.8M 0.01% 955

Other funds holding LH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Raymond James Financial's LH Position: Q1 2026 in Review

Raymond James Financial reduced its Labcorp (LH) stake by 12% in Q1 2026, selling an estimated $3.72M and leaving 103,341 shares worth $27.6M. The position accounts for 0.01% of the portfolio, ranked #1249.

Raymond James Financial first reported a position in LH in Q4 2024 and has held it in 6 quarters since. The position peaked at $41.8M in Q2 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Raymond James Financial held 103,341 shares of Labcorp worth $27.6M as of Q1 2026.
  • Raymond James Financial sold 13,754 Labcorp shares in Q1 2026, an estimated $3.72M.
  • Labcorp made up 0.01% of Raymond James Financial's portfolio in Q1 2026, its #1249 holding.
  • Raymond James Financial first reported a position in Labcorp in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Labcorp position peaked at $41.8M in Q2 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.